REG1B and REG3G as potential serum biomarkers for diagnosis and severity stratification of atherosclerosis

This study aimed to investigate the clinical significance of regenerating islet-derived (REG) proteins, specifically REG1B and REG3G, as novel circulating biomarkers for distinguishing atherosclerosis (AS) patients from healthy individuals and for severity assessment with particular emphasis on their association with lipid metabolism and lipid-driven vascular inflammation. Serum levels of REG proteins were measured by enzyme-linked immunosorbent assay (ELISA) in a clinical cohort comprising 172 AS patients and 115 healthy controls. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis and correlated with disease severity assessed by angiographic Gensini score and the number of obstructed vessels. An ApoE −/− rat model of lipid-driven atherosclerosis was employed for validation. Protein expression and circulating biomarkers were assessed by IHC, ELISA, and RT-qPCR. Transcriptomic analysis and weighted gene co-expression network analysis (WGCNA) were performed on rat aortic tissues to characterize molecular networks associated with lipid accumulation and vascular inflammation. REG1B and REG3G levels were significantly elevated in AS patients compared to controls and showed positive correlations with disease severity. REG1B demonstrated favorable diagnostic accuracy (AUC = 0.882) and remained elevated even in non-obstructive coronary atherosclerosis, outperforming conventional biomarkers such as hs-CRP, IL-8, and Hcy. In ApoE −/− rats, REG family proteins were upregulated in atherosclerotic aortas and circulation in parallel with progressive lipid deposition and plaque development. Network analysis revealed that Reg genes were embedded within a progressively activated immune-metabolic regulatory network associated with lipid accumulation, inflammatory activation, and atherogenesis. REG1B and REG3G are promising circulating biomarkers for AS, particularly in the context of lipid-driven vascular pathology. The ability of REG1B to remain elevated at the non-obstructive stage suggests potential for identifying coronary atherosclerosis in symptomatic populations. Their association with disease severity and integration within lipid-linked immune regulatory networks suggest potential roles in coordinating metabolic inflammation during atherogenesis.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2026-11-15
DOI
https://doi.org/10.1186/s40001-026-05425-2
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

REG1B and REG3G as potential serum biomarkers for diagnosis and severity stratification of atherosclerosis

Qingyan Huang, Zhikang Yu, Mingfeng Huang, Xuemin Guo
European journal of medical research
Atherosclerosis and Cardiovascular Diseases
article

REG1B and REG3G as potential serum biomarkers for diagnosis and severity stratification of atherosclerosis

Qingyan Huang, Zhikang Yu, Mingfeng Huang, Xuemin Guo
article en

Abstract

This study aimed to investigate the clinical significance of regenerating islet-derived (REG) proteins, specifically REG1B and REG3G, as novel circulating biomarkers for distinguishing atherosclerosis (AS) patients from healthy individuals and for severity assessment with particular emphasis on their association with lipid metabolism and lipid-driven vascular inflammation. Serum levels of REG proteins were measured by enzyme-linked immunosorbent assay (ELISA) in a clinical cohort comprising 172 AS patients and 115 healthy controls. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis and correlated with disease severity assessed by angiographic Gensini score and the number of obstructed vessels. An ApoE −/− rat model of lipid-driven atherosclerosis was employed for validation. Protein expression and circulating biomarkers were assessed by IHC, ELISA, and RT-qPCR. Transcriptomic analysis and weighted gene co-expression network analysis (WGCNA) were performed on rat aortic tissues to characterize molecular networks associated with lipid accumulation and vascular inflammation. REG1B and REG3G levels were significantly elevated in AS patients compared to controls and showed positive correlations with disease severity. REG1B demonstrated favorable diagnostic accuracy (AUC = 0.882) and remained elevated even in non-obstructive coronary atherosclerosis, outperforming conventional biomarkers such as hs-CRP, IL-8, and Hcy. In ApoE −/− rats, REG family proteins were upregulated in atherosclerotic aortas and circulation in parallel with progressive lipid deposition and plaque development. Network analysis revealed that Reg genes were embedded within a progressively activated immune-metabolic regulatory network associated with lipid accumulation, inflammatory activation, and atherogenesis. REG1B and REG3G are promising circulating biomarkers for AS, particularly in the context of lipid-driven vascular pathology. The ability of REG1B to remain elevated at the non-obstructive stage suggests potential for identifying coronary atherosclerosis in symptomatic populations. Their association with disease severity and integration within lipid-linked immune regulatory networks suggest potential roles in coordinating metabolic inflammation during atherogenesis.

European journal of medical research
Meizhou City People's Hospital (CN)
Atherosclerosis and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon